Discussion Panel Bilal Piperdi, MD Associate Professor of Clinical Medicine Department of Medicine (Oncology) Albert Einstein College of Medicine of Yeshiva University Bronx, NY
Steven Keller, MD Professor of Clinical Cardiovascular & Thoracic Surgery Department of Cardiovascular & Thoracic Surgery Albert Einstein College of Medicine of Yeshiva University Bronx, NY
Chirag Shah, MD Assistant Professor of Medicine Divisions of Pulmonary and Critical Care Medicine Montefiore Medical Center Albert Einstein College of Medicine of Yeshiva University Bronx, NY
AMA PRA Category 1 Credit TM Medium
This roundtable discussion features key participants in a quality improvement initiative to improve rates of molecular testing in NSCLC at Albert Einstein College of Medicine of Yeshiva University/Montefiore Medical Center. The discussion provides background information about the clinical significance of NSCLC molecular testing, reviews baseline data on Montefiore/Einstein molecular testing in NSCLC, describes internal processes that were refined with regard to molecular testing, and identifies system barriers and opportunities for quality improvement to impart "lessons learned" for clinicians elsewhere.
For guidance on implementing a similar initiative at your institution, click
here to access "Molecular Testing in NSCLC: A Quality Improvement Toolkit."
This activity is jointly provided by Albert Einstein College of Medicine and Montefiore Medical Center, and MCM Education.
Oncologists, pulmonologists and interventional radiologists (who perform lung biopsies), pathologists, and other oncology clinicians involved in the treatment of patients with NSCLC.
Upon completion of this educational activity, the participant should be able to:
Discuss the importance of obtaining adequate tissue samples at biopsy of patients with NSCLC in order to do molecular testing.
Discuss the impact of an inadequate tissue sample on patient treatment and outcomes.
Identify targeted treatments that would be indicated for patients with advanced NSCLC with positive biomarker findings.
Explain the challenges that may arise in obtaining an adequate tissue sample and strategies to overcome these challenges.
The “Conflict of Interest Disclosure Policies” of Albert Einstein College of Medicine of Yeshiva University require that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
The Albert Einstein College of Medicine of Yeshiva University (Einstein) also require that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.
Contributors whose COIs are irresolvable are not permitted to participate in Einstein CME activities.
Bilal Piperdi, MD, has no financial conflicts to disclose.
The staff of CCME of Albert Einstein College of Medicine have no disclosures to report with any commercial interests relative to this CME activity.
Joeseph Kim, MD, MPH, (MCM Education, President) has no financial conflicts to disclose.
Sarah Zimov, PhD, (MCM Writer) has no financial conflicts to disclose.
Kathleen Hines (MCM Education, Editorial Director) has no financial conflicts to disclose. Credit Statements
ACCME ACCREDITATION STATEMENT: This activity has been planned and implemented in accordance with the requirements and procedures of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center, and MCM Education. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
ACCME CREDIT DESIGNATION STATEMENT: Albert Einstein College of Medicine of Yeshiva University designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in each activity.
Commercial Support Statements
Supported by independent educational grants from Lilly; Boehringer Ingelheim Pharmaceuticals, Inc.; and Genentech.
There are no fees for participating in or receiving credit for this online educational activity. This activity is designed to be completed within the time designated on this page; physicians should claim only those credits that reflect the time actually spent in the activity.
Review the intended audience, learning objectives, and author disclosures.
Study the educational content online.
Once completed, continue to post-test. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must also complete the Activity Evaluation.
Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
Presented by Albert Einstein College of Medicine and Montefiore Medical Center, Center for Continuing Medical Education; and MCM Education.
The opinions expressed in these educational activities are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions; the publisher; Albert Einstein College of Medicine and Montefiore Medical Center, Center for Continuing Medical Education; Eli Lilly and Company; Boehringer Ingleheim, Inc.; or Genentech. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.